Regulation of IL-17 in autoimmune diseases by transcriptional factors and microRNAs

Frontiers in Genetics

Volumn 6, Issue JUL, 2015, Pages

  Khan, Deena ^a,b   Ahmed, S Ansar ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Autoimmune; Inflammation; Interleukin 17; MicroRNA; Transcription

Indexed keywords

BRODALUMAB; GUSELKUMAB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 6; IXEKIZUMAB; MICRORNA 155; ORPHAN NUCLEAR RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; RHEUMATOID FACTOR; SECUKINUMAB; SIRTUIN 1; STAT3 PROTEIN; STAT4 PROTEIN; STAT6 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA1; UNINDEXED DRUG; USTEKINUMAB;

AUTOIMMUNE DISEASE; B CELL LYMPHOMA; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; COLLAGEN-INDUCED ARTHRITIS; DNA BINDING; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; HISTONE MODIFICATION; HUMAN; INNATE IMMUNITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PSORIASIS; RHEUMATOID ARTHRITIS; SHORT SURVEY; SIGNAL TRANSDUCTION; TH17 CELL; TRANSCRIPTION REGULATION;

EID: 84940107223     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2015.00236     Document Type: Short Survey

References (128)

1. Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A., and Sallusto, F. (2007). Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8, 942-949. doi: 10.1038/ni1496.
2. Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J., and Gurney, A. L. (2003). Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278, 1910-1914. doi: 10.1074/jbc.M207577200.
3. An, J., Golech, S., Klaewsongkram, J., Zhang, Y., Subedi, K., Huston, G. E., et al. (2011). Kruppel-like factor 4 (KLF4) directly regulates proliferation in thymocyte development and IL-17 expression during Th17 differentiation. FASEB J. 25, 3634-3645. doi: 10.1096/fj.11-186924.
4. Andoh, A., Takaya, H., Makino, J., Sato, H., Bamba, S., Araki, Y., et al. (2001). Cooperation of interleukin-17 and interferon-gamma on chemokine secretion in human fetal intestinal epithelial cells. Clin. Exp. Immunol. 125, 56-63. doi: 10.1046/j.1365-2249.2001.01588.x.
5. Arisawa, T., Tahara, T., Shiroeda, H., Matsue, Y., Minato, T., Nomura, T., et al. (2012). Genetic polymorphisms of IL17A and pri-microRNA-938, targeting IL17A 3'-UTR, influence susceptibility to gastric cancer. Hum. Immunol. 73, 747-752. doi: 10.1016/j.humimm.2012.04.011.
6. Babaloo, Z., Aliparasti, M., Babaie, F., Almasi, S., Baradaran, B., and Farhoodi, M. (2015). The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: interleukin-17A and interleukin-17F serum levels. Immunol. Lett. 164, 76-80. doi: 10.1016/j.imlet.2015.01.001.
7. Babon, J. J., Varghese, L. N., and Nicola, N. A. (2014). Inhibition of IL-6 family cytokines by SOCS3. Semin. Immunol. 26, 13-19. doi: 10.1016/j.smim.2013.12.004.
8. Batten, M., Li, J., Yi, S., Kljavin, N. M., Danilenko, D. M., Lucas, S., et al. (2006). Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7, 929-936. doi: 10.1038/ni1375.
9. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., et al. (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238. doi: 10.1038/nature04753.
10. Biswas, P. S., Gupta, S., Chang, E., Song, L., Stirzaker, R. A., Liao, J. K., et al. (2010). Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. J. Clin. Invest. 120, 3280-3295. doi: 10.1172/JCI42856.
11. Bluml, S., Bonelli, M., Niederreiter, B., Puchner, A., Mayr, G., Hayer, S., et al. (2011). Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice. Arthritis Rheum. 63, 1281-1288. doi: 10.1002/art.30281.
12. Brustle, A., Heink, S., Huber, M., Rosenplanter, C., Stadelmann, C., Yu, P., et al. (2007). The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 8, 958-966. doi: 10.1038/ni1500.
13. Castro-Villegas, C., Perez-Sanchez, C., Escudero, A., Filipescu, I., Verdu, M., Ruiz-Limon, P., et al. (2015). Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFalpha. Arthritis Res. Ther. 17:49. doi: 10.1186/s13075-015-0555-z.
14. Chen, Z., Laurence, A., Kanno, Y., Pacher-Zavisin, M., Zhu, B. M., Tato, C., et al. (2006). Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl. Acad. Sci. U.S.A. 103, 8137-8142. doi: 10.1073/pnas.0600666103.
15. Choi, B., Kim, H. A., Suh, C. H., Byun, H. O., Jung, J. Y., and Sohn, S. (2015). The relevance of miRNA-21 in HSV-induced inflammation in a mouse model. Int. J. Mol. Sci. 16, 7413-7427. doi: 10.3390/ijms16047413.
16. Ciofani, M., Madar, A., Galan, C., Sellars, M., Mace, K., Pauli, F., et al. (2012). A validated regulatory network for Th17 cell specification. Cell 151, 289-303. doi: 10.1016/j.cell.2012.09.016.
17. Cua, D. J., and Tato, C. M. (2010). Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10, 479-489. doi: 10.1038/nri2800.
18. Dai, R., and Ahmed, S. A. (2011). MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl. Res. 157, 163-179. doi: 10.1016/j.trsl.2011.01.007.
19. Dai, R., McReynolds, S., Leroith, T., Heid, B., Liang, Z., and Ahmed, S. A. (2013). Sex differences in the expression of lupus-associated miRNAs in splenocytes from lupus-prone NZB/WF1 mice. Biol. Sex. Differ. 4:19. doi: 10.1186/2042-6410-4-19.
20. Dong, L., Wang, X., Tan, J., Li, H., Qian, W., Chen, J., et al. (2014). Decreased expression of microRNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis. J. Cell. Mol. Med. 18, 2213-2224. doi: 10.1111/jcmm.12353.
21. Du, C., Liu, C., Kang, J., Zhao, G., Ye, Z., Huang, S., et al. (2009). MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat. Immunol. 10, 1252-1259. doi: 10.1038/ni.1798.
22. Duhen, T., and Campbell, D. J. (2014). IL-1beta promotes the differentiation of polyfunctional human CCR6+CXCR3+ Th1/17 cells that are specific for pathogenic and commensal microbes. J. Immunol. 193, 120-129. doi: 10.4049/jimmunol.1302734.
23. Francois, A., Gombault, A., Villeret, B., Alsaleh, G., Fanny, M., Gasse, P., et al. (2015). B cell activating factor is central to bleomycin-and IL-17-mediated experimental pulmonary fibrosis. J. Autoimmun. 56, 1-11. doi: 10.1016/j.jaut.2014.08.003.
24. Fujita-Sato, S., Ito, S., Isobe, T., Ohyama, T., Wakabayashi, K., Morishita, K., et al. (2011). Structural basis of digoxin that antagonizes RORgamma t receptor activity and suppresses Th17 cell differentiation and interleukin (IL)-17 production. J. Biol. Chem. 286, 31409-31417. doi: 10.1074/jbc.M111.254003.
25. Gelderblom, M., Arunachalam, P., and Magnus, T. (2014). gammadelta T cells as early sensors of tissue damage and mediators of secondary neurodegeneration. Front. Cell. Neurosci. 8:368. doi: 10.3389/fncel.2014.00368.
26. Gocke, A. R., Cravens, P. D., Ben, L. H., Hussain, R. Z., Northrop, S. C., Racke, M. K., et al. (2007). T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity. J. Immunol. 178, 1341-1348. doi: 10.4049/jimmunol.178.3.1341.
27. Grange, M., Verdeil, G., Arnoux, F., Griffon, A., Spicuglia, S., Maurizio, J., et al. (2013). Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-beta1 signaling. J. Immunol. 191, 3712-3724. doi: 10.4049/jimmunol.1300319.
28. Haas, J. D., Nistala, K., Petermann, F., Saran, N., Chennupati, V., Schmitz, S., et al. (2011). Expression of miRNAs miR-133b and miR-206 in the Il17a/f locus is co-regulated with IL-17 production in alphabeta and gammadelta T cells. PLoS ONE 6:e20171. doi: 10.1371/journal.pone.0020171.
29. Hanieh, H., and Alzahrani, A. (2013). MicroRNA-132 suppresses autoimmune encephalomyelitis by inducing cholinergic anti-inflammation: a new Ahr-based exploration. Eur. J. Immunol. 43, 2771-2782. doi: 10.1002/eji.201343486.
30. Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., et al. (2005). Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123-1132. doi: 10.1038/ni1254.
31. Hayes, M. D., Ovcinnikovs, V., Smith, A. G., Kimber, I., and Dearman, R. J. (2014). The aryl hydrocarbon receptor: differential contribution to T helper 17 and T cytotoxic 17 cell development. PLoS ONE 9:e106955. doi: 10.1371/journal.pone.0106955.
32. Hirota, K., Duarte, J. H., Veldhoen, M., Hornsby, E., Li, Y., Cua, D. J., et al. (2011). Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12, 255-263. doi: 10.1038/ni.1993.
33. Huang, M. C., Liao, J. J., Bonasera, S., Longo, D. L., and Goetzl, E. J. (2008). Nuclear factor-kappaB-dependent reversal of aging-induced alterations in T cell cytokines. FASEB J. 22, 2142-2150. doi: 10.1096/fj.07-103721.
34. Huber, M., Brustle, A., Reinhard, K., Guralnik, A., Walter, G., Mahiny, A., et al. (2008). IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc. Natl. Acad. Sci. U.S.A. 105, 20846-20851. doi: 10.1073/pnas.0809077106.
35. Huber, M., and Lohoff, M. (2014). IRF4 at the crossroads of effector T-cell fate decision. Eur. J. Immunol. 44, 1886-1895. doi: 10.1002/eji.201344279.
36. Hueber, A. J., Asquith, D. L., Miller, A. M., Reilly, J., Kerr, S., Leipe, J., et al. (2010). Mast cells express IL-17A in rheumatoid arthritis synovium. J. Immunol. 184, 3336-3340. doi: 10.4049/jimmunol.0903566.
37. Huh, J. R., Leung, M. W., Huang, P., Ryan, D. A., Krout, M. R., Malapaka, R. R., et al. (2011). Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORgammat activity. Nature 472, 486-490. doi: 10.1038/nature09978.
38. Ichihara, A., Jinnin, M., Oyama, R., Yamane, K., Fujisawa, A., Sakai, K., et al. (2012). Increased serum levels of miR-1266 in patients with psoriasis vulgaris. Eur. J. Dermatol. 22, 68-71.
39. Ichiyama, K., Yoshida, H., Wakabayashi, Y., Chinen, T., Saeki, K., Nakaya, M., et al. (2008). Foxp3 inhibits RORgammat-mediated IL-17A mRNA transcription through direct interaction with RORgammat. J. Biol. Chem. 283, 17003-17008. doi: 10.1074/jbc.M801286200.
40. Ikeda, S., Saijo, S., Murayama, M. A., Shimizu, K., Akitsu, A., and Iwakura, Y. (2014). Excess IL-1 signaling enhances the development of Th17 cells by downregulating TGF-beta-induced Foxp3 expression. J. Immunol. 192, 1449-1458. doi: 10.4049/jimmunol.1300387.
41. Ishida, W., Fukuda, K., Sakamoto, S., Koyama, N., Koyanagi, A., Yagita, H., et al. (2011). Regulation of experimental autoimmune uveoretinitis by anti-delta-like ligand 4 monoclonal antibody. Invest. Ophthalmol. Vis. Sci. 52, 8224-8230. doi: 10.1167/iovs.11-7756.
42. Ivanov, II, McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., et al. (2006). The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121-1133. doi: 10.1016/j.cell.2006.07.035.
43. Jiang, W., Su, J., Zhang, X., Cheng, X., Zhou, J., Shi, R., et al. (2014). Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease. Inflamm. Res. 63, 943-950. doi: 10.1007/s00011-014-0768-7.
44. Jordan-Williams, K. L., Poston, S., and Taparowsky, E. J. (2013). BATF regulates the development and function of IL-17 producing iNKT cells. BMC Immunol. 14:16. doi: 10.1186/1471-2172-14-16.
45. Kang, Z., Altuntas, C. Z., Gulen, M. F., Liu, C., Giltiay, N., Qin, H., et al. (2010). Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 32, 414-425. doi: 10.1016/j.immuni.2010.03.004.
46. Khan, D., Dai, R., and Ansar Ahmed, S. (2015). Sex differences and estrogen regulation of miRNAs in lupus, a prototypical autoimmune disease. Cell. Immunol. 294, 70-79. doi: 10.1016/j.cellimm.2015.01.004.
47. Kim, K. W., Cho, M. L., Park, M. K., Yoon, C. H., Park, S. H., Lee, S. H., et al. (2005). Increased interleukin-17 production via a phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent pathway in patients with rheumatoid arthritis. Arthritis Res. Ther. 7, R139-R148. doi: 10.1186/ar1470.
48. Kleinschek, M. A., Owyang, A. M., Joyce-Shaikh, B., Langrish, C. L., Chen, Y., Gorman, D. M., et al. (2007). IL-25 regulates Th17 function in autoimmune inflammation. J. Exp. Med. 204, 161-170. doi: 10.1084/jem.20061738.
49. Kleinsteuber, K., Heesch, K., Schattling, S., Kohns, M., Sander-Jülch, C., Walzl, G., et al. (2013). Decreased expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4+ T cells and peripheral blood from tuberculosis patients. PLoS ONE 8:e61609. doi: 10.1371/journal.pone.0061609.
50. Klotz, L., Burgdorf, S., Dani, I., Saijo, K., Flossdorf, J., Hucke, S., et al. (2009). The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity. J. Exp. Med. 206, 2079-2089. doi: 10.1084/jem.20082771.
51. Kurschus, F. C., Croxford, A. L., Heinen, A. P., Wortge, S., Ielo, D., and Waisman, A. (2010). Genetic proof for the transient nature of the Th17 phenotype. Eur. J. Immunol. 40, 3336-3346. doi: 10.1002/eji.201040755.
52. Lazarevic, V., Chen, X., Shim, J. H., Hwang, E. S., Jang, E., Bolm, A. N., et al. (2011). T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORgammat. Nat. Immunol. 12, 96-104. doi: 10.1038/ni.1969.
53. Lebson, L., Gocke, A., Rosenzweig, J., Alder, J., Civin, C., Calabresi, P. A., et al. (2010). Cutting edge: the transcription factor Kruppel-like factor 4 regulates the differentiation of Th17 cells independently of RORgammat. J. Immunol. 185, 7161-7164. doi: 10.4049/jimmunol.1002750.
54. Lee, Y., Awasthi, A., Yosef, N., Quintana, F. J., Xiao, S., Peters, A., et al. (2012). Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 13, 991-999. doi: 10.1038/ni.2416.
55. Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., et al. (2012). Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N. Engl. J. Med. 366, 1190-1199. doi: 10.1056/NEJMoa1109997.
56. Li, L., Patsoukis, N., Petkova, V., and Boussiotis, V. A. (2012). Runx1 and Runx3 are involved in the generation and function of highly suppressive IL-17-producing T regulatory cells. PLoS ONE 7:e45115. doi: 10.1371/journal.pone.0045115.
57. Li, S., Joseph, C., Becourt, C., Klibi, J., Luce, S., Dubois-Laforgue, D., et al. (2014a). Potential role of IL-17-producing iNKT cells in type 1 diabetes. PLoS ONE 9:e96151. doi: 10.1371/journal.pone.0096151.
58. Li, Y., Li, D., Yan, Z., Qi, K., Chen, L., Zhang, Z., et al. (2014b). Potential relationship and clinical significance of miRNAs and Th17 cytokines in patients with multiple myeloma. Leuk. Res. 38, 1130-1135. doi: 10.1016/j.leukres.2014.07.005.
59. Li, Z., Wu, F., Brant, S. R., and Kwon, J. H. (2011). IL-23 receptor regulation by Let-7f in human CD4+ memory T cells. J. Immunol. 186, 6182-6190. doi: 10.4049/jimmunol.1000917.
60. Liang, S. C., Long, A. J., Bennett, F., Whitters, M. J., Karim, R., Collins, M., et al. (2007). An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J. Immunol. 179, 7791-7799. doi: 10.4049/jimmunol.179.11.7791.
61. Liao, J. J., Huang, M. C., and Goetzl, E. J. (2007). Cutting edge: alternative signaling of Th17 cell development by sphingosine 1-phosphate. J. Immunol. 178, 5425-5428. doi: 10.4049/jimmunol.178.9.5425.
62. Lim, H. W., Kang, S. G., Ryu, J. K., Schilling, B., Fei, M., Lee, I. S., et al. (2015). SIRT1 deacetylates RORgammat and enhances Th17 cell generation. J. Exp. Med. 212, 607-617. doi: 10.1084/jem.20132378.
63. Lin, A. M., Rubin, C. J., Khandpur, R., Wang, J. Y., Riblett, M., Yalavarthi, S., et al. (2011). Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J. Immunol. 187, 490-500. doi: 10.4049/jimmunol.1100123.
64. Liu, G., Guo, J., Liu, J., Wang, Z., and Liang, D. (2014a). Toll-like receptor signaling directly increases functional IL-17RA expression in neuroglial cells. Clin. Immunol. 154, 127-140. doi: 10.1016/j.clim.2014.07.006.
65. Liu, X., He, F., Pang, R., Zhao, D., Qiu, W., Shan, K., et al. (2014b). Interleukin-17 (IL-17)-induced microRNA 873 (miR-873) contributes to the pathogenesis of experimental autoimmune encephalomyelitis by targeting A20 ubiquitin-editing enzyme. J. Biol. Chem. 289, 28971-28986. doi: 10.1074/jbc.M114.577429.
66. Liu, H. P., Cao, A. T., Feng, T., Li, Q., Zhang, W., Yao, S., et al. (2015). TGF-beta converts Th1 cells into Th17 cells through stimulation of Runx1 expression. Eur. J. Immunol. 45, 1010-1018. doi: 10.1002/eji.201444726.
67. Liu, Y. L., Wu, W., Xue, Y., Gao, M., Yan, Y., Kong, Q., et al. (2013). MicroRNA-21 and-146b are involved in the pathogenesis of murine viral myocarditis by regulating TH-17 differentiation. Arch. Virol. 158, 1953-1963.
68. Manel, N., Unutmaz, D., and Littman, D. R. (2008). The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 9, 641-649. doi: 10.1038/ni.1610.
69. Mangan, P. R., Su, L. J., Jenny, V., Tatum, A. L., Picarillo, C., Skala, S., et al. (2015). Dual inhibition of IL-23 and IL-17 offers superior efficacy in mouse models of autoimmunity. J. Pharmacol. Exp. Ther. doi: 10.1124/jpet.115.224246 [Epub ahead of print].
70. Matsuyama, H., Suzuki, H. I., Nishimori, H., Noguchi, M., Yao, T., Komatsu, N., et al. (2011). miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma. Blood 118, 6881-6892. doi: 10.1182/blood-2011-05-354654.
71. McGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T., et al. (2007). TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 8, 1390-1397. doi: 10.1038/ni1539.
72. Mease, P. J. (2015). Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis. Curr. Opin. Rheumatol. 27, 127-133. doi: 10.1097/BOR.0000000000000147.
73. Miao, T., Raymond, M., Bhullar, P., Ghaffari, E., Symonds, A. L., Meier, U. C., et al. (2013). Early growth response gene-2 controls IL-17 expression and Th17 differentiation by negatively regulating Batf. J. Immunol. 190, 58-65. doi: 10.4049/jimmunol.1200868.
74. Moisan, J., Grenningloh, R., Bettelli, E., Oukka, M., and Ho, I. C. (2007). Ets-1 is a negative regulator of Th17 differentiation. J. Exp. Med. 204, 2825-2835. doi: 10.1084/jem.20070994.
75. Mudter, J., Yu, J., Zufferey, C., Brustle, A., Wirtz, S., Weigmann, B., et al. (2011). IRF4 regulates IL-17A promoter activity and controls RORgammat-dependent Th17 colitis in vivo. Inflamm. Bowel Dis. 17, 1343-1358. doi: 10.1002/ibd.21476.
76. Murugaiyan, G., Beynon, V., Mittal, A., Joller, N., and Weiner, H. L. (2011). Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 187, 2213-2221. doi: 10.4049/jimmunol.1003952.
77. Murugaiyan, G., da Cunha, A. P., Ajay, A. K., Joller, N., Garo, L. P., Kumaradevan, S., et al. (2015). MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis. J. Clin. Invest. 125, 1069-1080. doi: 10.1172/JCI74347.
78. Nakahama, T., Hanieh, H., Nguyen, N. T., Chinen, I., Ripley, B., Millrine, D., et al. (2013). Aryl hydrocarbon receptor-mediated induction of the microRNA-132/212 cluster promotes interleukin-17-producing T-helper cell differentiation. Proc. Natl. Acad. Sci. U.S.A. 110, 11964-11969. doi: 10.1073/pnas.1311087110.
79. Nardinocchi, L., Sonego, G., Passarelli, F., Avitabile, S., Scarponi, C., Failla, C. M., et al. (2014). Interleukin-17 and interleukin-22 promote tumor progression in human nonmelanoma skin cancer. Eur. J. Immunol. 45, 922-931. doi: 10.1002/eji.201445052.
80. Niimoto, T., Nakasa, T., Ishikawa, M., Okuhara, A., Izumi, B., Deie, M., et al. (2010). MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients. BMC Musculoskelet. Disord. 11:209. doi: 10.1186/1471-2474-11-209.
81. Nishihara, M., Ogura, H., Ueda, N., Tsuruoka, M., Kitabayashi, C., Tsuji, F., et al. (2007). IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state. Int. Immunol. 19, 695-702. doi: 10.1093/intimm/dxm045.
82. Numasaki, M., Lotze, M. T., and Sasaki, H. (2004). Interleukin-17 augments tumor necrosis factor-alpha-induced elaboration of proangiogenic factors from fibroblasts. Immunol. Lett. 93, 39-43. doi: 10.1016/j.imlet.2004.01.014.
83. O'Connell, R. M., Kahn, D., Gibson, W. S., Round, J. L., Scholz, R. L., Chaudhuri, A. A., et al. (2010). MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33, 607-619. doi: 10.1016/j.immuni.2010.09.009.
84. Oertli, M., Engler, D. B., Kohler, E., Koch, M., Meyer, T. F., and Müller, A. (2011). MicroRNA-155 is essential for the T cell-mediated control of Helicobacter pylori infection and for the induction of chronic Gastritis and Colitis. J. Immunol. 187, 3578-3586. doi: 10.4049/jimmunol.1101772.
85. Ouyang, X., Zhang, R., Yang, J., Li, Q., Qin, L., Zhu, C., et al. (2011). Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation. Nat. Commun. 2:314. doi: 10.1038/ncomms1311.
86. Papp, K., Cather, J. C., Rosoph, L., Sofen, H., Langley, R. G., Matheson, R. T., et al. (2012). Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial. Lancet 380, 738-746. doi: 10.1016/S0140-6736(12)60642-4.
87. Park, J. S., Lee, J., Lim, M. A., Kim, E. K., Kim, S. M., Ryu, J. G., et al. (2014). JAK2-STAT3 blockade by AG490 suppresses autoimmune arthritis in mice via reciprocal regulation of regulatory T cells and Th17 cells. J. Immunol. 192, 4417-4424. doi: 10.4049/jimmunol.1300514.
88. Pham, D., Sehra, S., Sun, X., and Kaplan, M. H. (2014). The transcription factor Etv5 controls TH17 cell development and allergic airway inflammation. J. Allergy Clin. Immunol. 134, 204-214. doi: 10.1016/j.jaci.2013.12.021.
89. Qi, C. F., Li, Z., Raffeld, M., Wang, H., Kovalchuk, A. L., and Morse, H. C. III (2009). Differential expression of IRF8 in subsets of macrophages and dendritic cells and effects of IRF8 deficiency on splenic B cell and macrophage compartments. Immunol. Res. 45, 62-74. doi: 10.1007/s12026-008-8032-2.
90. Qi, J., Yang, Y., Hou, S., Qiao, Y., Wang, Q., Yu, H., et al. (2014). Increased Notch pathway activation in Behcet's disease. Rheumatology (Oxford) 53, 810-820. doi: 10.1093/rheumatology/ket438.
91. Qiu, Z., Dillen, C., Hu, J., Verbeke, H., Struyf, S., Van Damme, J., et al. (2009). Interleukin-17 regulates chemokine and gelatinase B expression in fibroblasts to recruit both neutrophils and monocytes. Immunobiology 214, 835-842. doi: 10.1016/j.imbio.2009.06.007.
92. Rachitskaya, A. V., Hansen, A. M., Horai, R., Li, Z., Villasmil, R., Luger, D., et al. (2008). Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J. Immunol. 180, 5167-5171. doi: 10.4049/jimmunol.180.8.5167.
93. Ravichandran, J., Jackson, R. J., Trivedi, S., and Ranasinghe, C. (2014). IL-17A Expression in HIV-specific CD8 T cells is regulated by IL-4/IL-13 following HIV-1 prime-boost immunization. J. Interferon Cytokine Res. 35, 176-185. doi: 10.1089/jir.2014.0078.
94. Rodgers, J. M., Robinson, A. P., Rosler, E. S., Lariosa-Willingham, K., Persons, R. E., Dugas, J. C., et al. (2014). IL-17A activates ERK1/2 and enhances differentiation of oligodendrocyte progenitor cells. Glia 63, 768-779. doi: 10.1002/glia.22783.
95. Rouvier, E., Luciani, M. F., Mattéi, M. G., Denizot, F., and Golstein, P. (1993). CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J. Immunol. 150, 5445-5456.
96. Ruan, Q., Kameswaran, V., Zhang, Y., Zheng, S., Sun, J., Wang, J., et al. (2011). The Th17 immune response is controlled by the Rel-RORgamma-RORgamma T transcriptional axis. J. Exp. Med. 208, 2321-2333. doi: 10.1084/jem.20110462.
97. Schaefer, J. S., Montufar-Solis, D., Vigneswaran, N., and Klein, J. R. (2011). Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-10-/-mice precedes expression in the colon. J. Immunol. 187, 5834-5841. doi: 10.4049/jimmunol.1100922.
98. Skepner, J., Ramesh, R., Trocha, M., Schmidt, D., Baloglu, E., Lobera, M., et al. (2014). Pharmacologic inhibition of RORgammat regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo. J. Immunol. 192, 2564-2575. doi: 10.4049/jimmunol.1302190.
99. Sofen, H., Smith, S., Matheson, R. T., Leonardi, C. L., Calderon, C., Brodmerkel, C., et al. (2014). Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis. J. Allergy Clin. Immunol. 133, 1032-1040. doi: 10.1016/j.jaci.2014.01.025.
100. Sutton, C. E., Lalor, S. J., Sweeney, C. M., Brereton, C. F., Lavelle, E. C., and Mills, K. H. (2009). Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31, 331-341. doi: 10.1016/j.immuni.2009.08.001.
101. Talaat, R. M., Mohamed, S. F., Bassyouni, I. H., and Raouf, A. A. (2015). Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: correlation with disease activity. Cytokine 72, 146-153. doi: 10.1016/j.cyto.2014.12.027.
102. Tang, S. C., Fan, X. H., Pan, Q. M., Sun, Q. S., and Liu, Y. (2015). Decreased expression of IL-27 and its correlation with Th1 and Th17 cells in progressive multiple sclerosis. J. Neurol. Sci. 348, 174-180. doi: 10.1016/j.jns.2014.11.035.
103. Vartoukian, S. R., Tilakaratne, W. M., Seoudi, N., Bombardieri, M., Bergmeier, L., Tappuni, A. R., et al. (2014). Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjogren's syndrome. Clin. Exp. Immunol. 177, 618-629. doi: 10.1111/cei.12377.
104. Verschoor, C. P., Dorrington, M. G., Novakowski, K. E., Kaiser, J., Radford, K., Nair, P., et al. (2014). MicroRNA-155 is required for clearance of Streptococcus pneumoniae from the nasopharynx. Infect. Immun. 82, 4824-4833. doi: 10.1128/IAI.02251-14.
105. Viladomiu, M., Hontecillas, R., Pedragosa, M., Carbo, A., Hoops, S., Michalak, P., et al. (2012). Modeling the role of peroxisome proliferator-activated receptor gamma and microRNA-146 in mucosal immune responses to Clostridium difficile. PLoS ONE 7:e47525. doi: 10.1371/journal.pone.0047525.
106. Volpe, E., Servant, N., Zollinger, R., Bogiatzi, S. I., Hupe, P., Barillot, E., et al. (2008). A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat. Immunol. 9, 650-657. doi: 10.1038/ni.1613.
107. Wang, J., Zheng, S., Xin, N., Dou, C., Fu, L., Zhang, X., et al. (2013). Identification of novel MicroRNA signatures linked to experimental autoimmune myasthenia gravis pathogenesis: down-regulated miR-145 promotes pathogenetic Th17 cell response. J. Neuroimmune Pharmacol. 8, 1287-1302. doi: 10.1007/s11481-013-9498-9.
108. Wang, W., Shao, S., Jiao, Z., Guo, M., Xu, H., and Wang, S. (2012). The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis. Rheumatol. Int. 32, 887-893. doi: 10.1007/s00296-010-1710-0.
109. Wang, Y., Godec, J., Ben-Aissa, K., Cui, K., Zhao, K., Pucsek, A. B., et al. (2014). The transcription factors T-bet and Runx are required for the ontogeny of pathogenic interferon-gamma-producing T helper 17 cells. Immunity 40, 355-366. doi: 10.1016/j.immuni.2014.01.002.
110. Weaver, C. T., and Murphy, K. M. (2007). The central role of the Th17 lineage in regulating the inflammatory/autoimmune axis. Semin. Immunol. 19, 351-352. doi: 10.1016/j.smim.2008.01.001.
111. Woltman, A. M., de Haij, S., Boonstra, J. G., Gobin, S. J., Daha, M. R., and van Kooten, C. (2000). Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J. Am. Soc. Nephrol. 11, 2044-2055.
112. Xia, P., Fang, X., Zhang, Z. H., Huang, Q., Yan, K. X., Kang, K. F., et al. (2012). Dysregulation of miRNA146a versus IRAK1 induces IL-17 persistence in the psoriatic skin lesions. Immunol. Lett. 148, 151-162. doi: 10.1016/j.imlet.2012.09.004.
113. Yang, H., Zhang, Y., Wu, M., Li, J., Zhou, W., Li, G., et al. (2010). Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile. Inflamm. Res. 59, 197-205. doi: 10.1007/s00011-009-0087-6.
114. Yang, L., Anderson, D. E., Baecher-Allan, C., Hastings, W. D., Bettelli, E., Oukka, M., et al. (2008a). IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 454, 350-352. doi: 10.1038/nature07021.
115. Yang, X. O., Pappu, B. P., Nurieva, R., Akimzhanov, A., Kang, H. S., Chung, Y., et al. (2008b). T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28, 29-39. doi: 10.1016/j.immuni.2007.11.016.
116. Yao, R., Ma, Y., Du, Y., Liao, M., Li, H., Liang, W., et al. (2011). The altered expression of inflammation-related microRNAs with microRNA-155 expression correlates with Th17 differentiation in patients with acute coronary syndrome. Cell. Mol. Immunol. 8, 486-495. doi: 10.1038/cmi.2011.22.
117. Yao, R., Ma, Y. L., Liang, W., Li, H. H., Ma, Z. J., Yu, X., et al. (2012). MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1. PLoS ONE 7:e46082. doi: 10.1371/journal.pone.0046082.
118. Yao, Z., Painter, S. L., Fanslow, W. C., Ulrich, D., Macduff, B. M., Spriggs, M. K., et al. (1995). Human IL-17: a novel cytokine derived from T cells. J. Immunol. 155, 5483-5486.
119. Ye, L., Jiang, B., Deng, J., Du, J., Xiong, W., Guan, Y., et al. (2015). IL-37 alleviates rheumatoid arthritis by suppressing IL-17 and IL-17-triggering cytokine production and limiting Th17 cell proliferation. J. Immunol. 194, 5110-5119. doi: 10.4049/jimmunol.1401810.
120. Yeh, W. I., McWilliams, I. L., and Harrington, L. E. (2014). IFNgamma inhibits Th17 differentiation and function via Tbet-dependent and Tbet-independent mechanisms. J. Neuroimmunol. 267, 20-27. doi: 10.1016/j.jneuroim.2013.12.001.
121. Yeilding, N., Szapary, P., Brodmerkel, C., Benson, J., Plotnick, M., Zhou, H., et al. (2011). Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives. Ann. N. Y. Acad. Sci. 1222, 30-39. doi: 10.1111/j.1749-6632.2011.05963.x.
122. Zanin-Zhorov, A., and Waksal, S. D. (2015). ROCKing cytokine secretion balance in human T cells. Cytokine 72, 224-225. doi: 10.1016/j.cyto.2014.12.025.
123. Zhang, F., Meng, G., and Strober, W. (2008). Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat. Immunol. 9, 1297-1306. doi: 10.1038/ni.1663.
124. Zhang, R., Tian, A., Wang, J., Shen, X., Qi, G., and Tang, Y. (2015). miR26a modulates Th17/T reg balance in the EAE model of multiple sclerosis by targeting IL6. Neuromol. Med. 17, 24-34. doi: 10.1007/s12017-014-8335-5.
125. Zhang, S., Liang, R., Luo, W., Liu, C., Wu, X., Gao, Y., et al. (2013). High susceptibility to liver injury in IL-27 p28 conditional knockout mice involves intrinsic interferon-gamma dysregulation of CD4+ T cells. Hepatology 57, 1620-1631. doi: 10.1002/hep.26166.
126. Zhao, F., Hoechst, B., Gamrekelashvili, J., Ormandy, L. A., Voigtlander, T., Wedemeyer, H., et al. (2012). Human CCR4+ CCR6+ Th17 cells suppress autologous CD8+ T cell responses. J. Immunol. 188, 6055-6062. doi: 10.4049/jimmunol.1102918.
127. Zhu, E., Wang, X., Zheng, B., Wang, Q., Hao, J., Chen, S., et al. (2014). miR-20b suppresses Th17 differentiation and the pathogenesis of experimental autoimmune encephalomyelitis by targeting RORgammat and STAT3. J. Immunol. 192, 5599-5609. doi: 10.4049/jimmunol.1303488.
128. Zhu, S., Pan, W., Song, X., Liu, Y., Shao, X., Tang, Y., et al. (2012). The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-alpha. Nat. Med. 18, 1077-1086. doi: 10.1038/nm.2815.